Le Lézard
Classified in: Health
Subject: RCL

Advisory - Unauthorized kratom products seized from Culture Rising store in Milton, ON


OTTAWA, July 7, 2017 /CNW/ -

Issue
Health Canada is advising Canadians that it has seized several unauthorized kratom products from Culture Rising at 1248 Main St E, Milton, ON. Kratom may pose serious health risks when swallowed or inhaled.

Health Canada has not authorized the sale any product containing kratom. It is illegal to sell any health products in Canada without authorization from Health Canada. The Department advises consumers not to swallow or inhale products labeled to contain kratom because of the potential side effects, including liver and heart problems.

Who is affected

Affected products

What consumers should do

What Health Canada is doing
Health Canada seized the products from the retail location. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians as necessary. Health Canada is also working with the Canada Border Services Agency to stop kratom products from entering Canada illegally.

Background
Kratom (Mitragyna speciosa) is a herbal product that may pose serious health risks when swallowed or inhaled. Side effects include drowsiness, nausea, vomiting, seizures, liver toxicity and excessively rapid heartbeat. Kratom has been linked to both narcotic and stimulant-like effects, and has potential for abuse and dependence.

For more information

Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: